Your business depends on your ability to construct a firm pathway to market-access for follow-on biopharmaceuticals - and every hour counts. With that in mind we are pleased to invite you to attend the 13th annual Business of Biosimilars and Generic Drugs – the only conference in the United States devoted entirely to giving you the tools you need for successful commercialization of biosimilars! Our expert faculty will provide you with senior executive-level expert insight on all of your critical success factors, including regulatory approval, IP challenges, and planning and coordinating an international product rollout strategy attuned to the needs of each market.
Featured Speakers include:
- - G. Steven Burrill, CEO, Burrill & Company presenting “Think Different - Navigating the Brave New Globalized Life Science Industry”
- - Alex Kudrin, Medical Director, Takeda Pharmaceuticals presenting “Access the Emerging BRIC Markets for Biosimilars”
- - Bassil Dahiyat, CEO, Xencor presenting “Learn How to Design Profitable Strategic Partnerships for Follow-On Biopharmaceutical Development”
The 13th Annual Business of Biosimilars and Generic Drugs will take place September 10-12, 2012 in Boston, MA. As a member of the Business of Biosimilars LinkedIn Group, you receive an exclusive discount of 25% off of the standard price when you register to join us. Simply use priority code XP1786LINK. Have any questions about the event? Feel free to contact Jennifer Pereira.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment